In September 2026, US existing home sales fell 2.5% year-over-year, driven by mortgage rates reaching 7.28%, the highest since November 2023. Newly pending sales, a predictor of future closings, dropped 8.5%. Despite a slight 1% rise in home values, monthly mortgage payments increased 6.7%, making buying less affordable. Meanwhile, the rental market strengthened with typical rents rising 2.7%, the largest annual increase since April 2025, as more buyers opt to rent amid high borrowing costs. The housing market slowdown is expected to continue through the fourth quarter, though potential rate declines could revive buyer and seller activity by spring.
Zillow's September housing market report shows a decline in pending sales and rising mortgage rates. For readers following the US real estate sector, here is Pluang's market snapshot as of Oct 06, 2026 18:13 WIB: out of 26 priced Real Estate-sector US stocks, 20 rose and 2 fell. Notably, NLY rose 0.33% with a typical hold time of 92 days and a 70% buy order activity, contrasting with VICI which fell 0.22% and had 69% sell order activity. JLL also gained 0.21% with 100% buy orders and a hold time of 71 days.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
